Loading…

APOBEC3A and 3C decrease human papillomavirus 16 pseudovirion infectivity

Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) proteins are cellular DNA/RNA-editing enzymes that play pivotal roles in the innate immune response to viral infection. APOBEC3 (A3) proteins were reported to hypermutate the genome of human papillomavirus 16 (HPV16), the caus...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2015-02, Vol.457 (3), p.295-299
Main Authors: Ahasan, Md Monjurul, Wakae, Kousho, Wang, Zhe, Kitamura, Kouichi, Liu, Guangyan, Koura, Miki, Imayasu, Mieko, Sakamoto, Naoya, Hanaoka, Kousei, Nakamura, Mitsuhiro, Kyo, Satoru, Kondo, Satoru, Fujiwara, Hiroshi, Yoshizaki, Tomokazu, Mori, Seiichiro, Kukimoto, Iwao, Muramatsu, Masamichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c630t-bc75bc636603380326c06442a5e1bfb5b50b49664532d3233738ac66130b49ff3
cites cdi_FETCH-LOGICAL-c630t-bc75bc636603380326c06442a5e1bfb5b50b49664532d3233738ac66130b49ff3
container_end_page 299
container_issue 3
container_start_page 295
container_title Biochemical and biophysical research communications
container_volume 457
creator Ahasan, Md Monjurul
Wakae, Kousho
Wang, Zhe
Kitamura, Kouichi
Liu, Guangyan
Koura, Miki
Imayasu, Mieko
Sakamoto, Naoya
Hanaoka, Kousei
Nakamura, Mitsuhiro
Kyo, Satoru
Kondo, Satoru
Fujiwara, Hiroshi
Yoshizaki, Tomokazu
Mori, Seiichiro
Kukimoto, Iwao
Muramatsu, Masamichi
description Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) proteins are cellular DNA/RNA-editing enzymes that play pivotal roles in the innate immune response to viral infection. APOBEC3 (A3) proteins were reported to hypermutate the genome of human papillomavirus 16 (HPV16), the causative agent of cervical cancer. However, hypermutation did not affect viral DNA maintenance, leaving the exact role of A3 against HPV infection elusive. Here we examine whether A3 proteins affect the virion assembly using an HPV16 pseudovirion (PsV) production system, in which PsVs are assembled from its capsid proteins L1/L2 encapsidating a reporter plasmid in 293FT cells. We found that co-expression of A3A or A3C in 293FT cells greatly reduced the infectivity of PsV. The reduced infectivity of PsV assembled in the presence of A3A, but not A3C, was attributed to the decreased copy number of the encapsidated reporter plasmid. On the other hand, A3C, but not A3A, efficiently bound to L1 in co-immunoprecipitation assays, which suggests that this physical interaction may lead to reduced infectivity of PsV assembled in the presence of A3C. These results provide mechanistic insights into A3s’ inhibitory effects on the assembly phase of the HPV16 virion. •APOBEC3A, and 3C decrease the infectivity of HPV16 pseudovirion.•APOBEC3A, but not 3C decreases the encapsidated DNA in the pseudovirion.•APOBEC3C, but not 3A binds to HPV16 capsid protein L1 in vitro.
doi_str_mv 10.1016/j.bbrc.2014.12.103
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1676353968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X14022955</els_id><sourcerecordid>1655726776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c630t-bc75bc636603380326c06442a5e1bfb5b50b49664532d3233738ac66130b49ff3</originalsourceid><addsrcrecordid>eNqNkEtLAzEUhYMoWqt_wIXM0s3Um9yZOx1wU4svEHSh4C4kmQymzMukU_Dfm1J1Ka5yc_jOWXyMnXGYceB0uZpp7c1MAM9mXMQM99iEQwmp4JDtswkAUCpK_nbEjkNYAXCeUXnIjkSeFzQnmrCHxfPT9c0SF4nqqgSXSWWNtyrY5H1sVZcManBN07dq4_wYEk7JEOxY9fHr-i5xXW3N2m3c-vOEHdSqCfb0-52y19ubl-V9-vh097BcPKaGENapNkWu40kEiHNAQQYoy4TKLde1znUOOiuJshxFhQKxwLkyRBy3eV3jlF3sdgfff4w2rGXrgrFNozrbj0FyKghzLGn-DzR6EFTEwpSJHWp8H4K3tRy8a5X_lBzk1rZcya1tubUtuYgZxtL59_6oW1v9Vn70RuBqB9goZOOsl8E42xlbOR-9yap3f-1_AXC9jXk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1655726776</pqid></control><display><type>article</type><title>APOBEC3A and 3C decrease human papillomavirus 16 pseudovirion infectivity</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Ahasan, Md Monjurul ; Wakae, Kousho ; Wang, Zhe ; Kitamura, Kouichi ; Liu, Guangyan ; Koura, Miki ; Imayasu, Mieko ; Sakamoto, Naoya ; Hanaoka, Kousei ; Nakamura, Mitsuhiro ; Kyo, Satoru ; Kondo, Satoru ; Fujiwara, Hiroshi ; Yoshizaki, Tomokazu ; Mori, Seiichiro ; Kukimoto, Iwao ; Muramatsu, Masamichi</creator><creatorcontrib>Ahasan, Md Monjurul ; Wakae, Kousho ; Wang, Zhe ; Kitamura, Kouichi ; Liu, Guangyan ; Koura, Miki ; Imayasu, Mieko ; Sakamoto, Naoya ; Hanaoka, Kousei ; Nakamura, Mitsuhiro ; Kyo, Satoru ; Kondo, Satoru ; Fujiwara, Hiroshi ; Yoshizaki, Tomokazu ; Mori, Seiichiro ; Kukimoto, Iwao ; Muramatsu, Masamichi</creatorcontrib><description>Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) proteins are cellular DNA/RNA-editing enzymes that play pivotal roles in the innate immune response to viral infection. APOBEC3 (A3) proteins were reported to hypermutate the genome of human papillomavirus 16 (HPV16), the causative agent of cervical cancer. However, hypermutation did not affect viral DNA maintenance, leaving the exact role of A3 against HPV infection elusive. Here we examine whether A3 proteins affect the virion assembly using an HPV16 pseudovirion (PsV) production system, in which PsVs are assembled from its capsid proteins L1/L2 encapsidating a reporter plasmid in 293FT cells. We found that co-expression of A3A or A3C in 293FT cells greatly reduced the infectivity of PsV. The reduced infectivity of PsV assembled in the presence of A3A, but not A3C, was attributed to the decreased copy number of the encapsidated reporter plasmid. On the other hand, A3C, but not A3A, efficiently bound to L1 in co-immunoprecipitation assays, which suggests that this physical interaction may lead to reduced infectivity of PsV assembled in the presence of A3C. These results provide mechanistic insights into A3s’ inhibitory effects on the assembly phase of the HPV16 virion. •APOBEC3A, and 3C decrease the infectivity of HPV16 pseudovirion.•APOBEC3A, but not 3C decreases the encapsidated DNA in the pseudovirion.•APOBEC3C, but not 3A binds to HPV16 capsid protein L1 in vitro.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2014.12.103</identifier><identifier>PMID: 25576866</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antiviral activity ; APOBEC3 ; Capsid Proteins - physiology ; Cytidine Deaminase - genetics ; Cytidine Deaminase - physiology ; Female ; Genome, Viral ; HEK293 Cells ; Host-Pathogen Interactions ; HPV16 ; Human papillomavirus 16 ; Human papillomavirus 16 - genetics ; Human papillomavirus 16 - pathogenicity ; Human papillomavirus 16 - physiology ; Humans ; Oncogene Proteins, Viral - physiology ; Protein Binding ; Proteins - genetics ; Proteins - physiology ; Pseudovirion ; Virion - genetics ; Virion - pathogenicity ; Virion - physiology ; Virulence ; Virus Assembly</subject><ispartof>Biochemical and biophysical research communications, 2015-02, Vol.457 (3), p.295-299</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c630t-bc75bc636603380326c06442a5e1bfb5b50b49664532d3233738ac66130b49ff3</citedby><cites>FETCH-LOGICAL-c630t-bc75bc636603380326c06442a5e1bfb5b50b49664532d3233738ac66130b49ff3</cites><orcidid>0000-0001-7767-6795</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25576866$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahasan, Md Monjurul</creatorcontrib><creatorcontrib>Wakae, Kousho</creatorcontrib><creatorcontrib>Wang, Zhe</creatorcontrib><creatorcontrib>Kitamura, Kouichi</creatorcontrib><creatorcontrib>Liu, Guangyan</creatorcontrib><creatorcontrib>Koura, Miki</creatorcontrib><creatorcontrib>Imayasu, Mieko</creatorcontrib><creatorcontrib>Sakamoto, Naoya</creatorcontrib><creatorcontrib>Hanaoka, Kousei</creatorcontrib><creatorcontrib>Nakamura, Mitsuhiro</creatorcontrib><creatorcontrib>Kyo, Satoru</creatorcontrib><creatorcontrib>Kondo, Satoru</creatorcontrib><creatorcontrib>Fujiwara, Hiroshi</creatorcontrib><creatorcontrib>Yoshizaki, Tomokazu</creatorcontrib><creatorcontrib>Mori, Seiichiro</creatorcontrib><creatorcontrib>Kukimoto, Iwao</creatorcontrib><creatorcontrib>Muramatsu, Masamichi</creatorcontrib><title>APOBEC3A and 3C decrease human papillomavirus 16 pseudovirion infectivity</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) proteins are cellular DNA/RNA-editing enzymes that play pivotal roles in the innate immune response to viral infection. APOBEC3 (A3) proteins were reported to hypermutate the genome of human papillomavirus 16 (HPV16), the causative agent of cervical cancer. However, hypermutation did not affect viral DNA maintenance, leaving the exact role of A3 against HPV infection elusive. Here we examine whether A3 proteins affect the virion assembly using an HPV16 pseudovirion (PsV) production system, in which PsVs are assembled from its capsid proteins L1/L2 encapsidating a reporter plasmid in 293FT cells. We found that co-expression of A3A or A3C in 293FT cells greatly reduced the infectivity of PsV. The reduced infectivity of PsV assembled in the presence of A3A, but not A3C, was attributed to the decreased copy number of the encapsidated reporter plasmid. On the other hand, A3C, but not A3A, efficiently bound to L1 in co-immunoprecipitation assays, which suggests that this physical interaction may lead to reduced infectivity of PsV assembled in the presence of A3C. These results provide mechanistic insights into A3s’ inhibitory effects on the assembly phase of the HPV16 virion. •APOBEC3A, and 3C decrease the infectivity of HPV16 pseudovirion.•APOBEC3A, but not 3C decreases the encapsidated DNA in the pseudovirion.•APOBEC3C, but not 3A binds to HPV16 capsid protein L1 in vitro.</description><subject>Antiviral activity</subject><subject>APOBEC3</subject><subject>Capsid Proteins - physiology</subject><subject>Cytidine Deaminase - genetics</subject><subject>Cytidine Deaminase - physiology</subject><subject>Female</subject><subject>Genome, Viral</subject><subject>HEK293 Cells</subject><subject>Host-Pathogen Interactions</subject><subject>HPV16</subject><subject>Human papillomavirus 16</subject><subject>Human papillomavirus 16 - genetics</subject><subject>Human papillomavirus 16 - pathogenicity</subject><subject>Human papillomavirus 16 - physiology</subject><subject>Humans</subject><subject>Oncogene Proteins, Viral - physiology</subject><subject>Protein Binding</subject><subject>Proteins - genetics</subject><subject>Proteins - physiology</subject><subject>Pseudovirion</subject><subject>Virion - genetics</subject><subject>Virion - pathogenicity</subject><subject>Virion - physiology</subject><subject>Virulence</subject><subject>Virus Assembly</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkEtLAzEUhYMoWqt_wIXM0s3Um9yZOx1wU4svEHSh4C4kmQymzMukU_Dfm1J1Ka5yc_jOWXyMnXGYceB0uZpp7c1MAM9mXMQM99iEQwmp4JDtswkAUCpK_nbEjkNYAXCeUXnIjkSeFzQnmrCHxfPT9c0SF4nqqgSXSWWNtyrY5H1sVZcManBN07dq4_wYEk7JEOxY9fHr-i5xXW3N2m3c-vOEHdSqCfb0-52y19ubl-V9-vh097BcPKaGENapNkWu40kEiHNAQQYoy4TKLde1znUOOiuJshxFhQKxwLkyRBy3eV3jlF3sdgfff4w2rGXrgrFNozrbj0FyKghzLGn-DzR6EFTEwpSJHWp8H4K3tRy8a5X_lBzk1rZcya1tubUtuYgZxtL59_6oW1v9Vn70RuBqB9goZOOsl8E42xlbOR-9yap3f-1_AXC9jXk</recordid><startdate>20150213</startdate><enddate>20150213</enddate><creator>Ahasan, Md Monjurul</creator><creator>Wakae, Kousho</creator><creator>Wang, Zhe</creator><creator>Kitamura, Kouichi</creator><creator>Liu, Guangyan</creator><creator>Koura, Miki</creator><creator>Imayasu, Mieko</creator><creator>Sakamoto, Naoya</creator><creator>Hanaoka, Kousei</creator><creator>Nakamura, Mitsuhiro</creator><creator>Kyo, Satoru</creator><creator>Kondo, Satoru</creator><creator>Fujiwara, Hiroshi</creator><creator>Yoshizaki, Tomokazu</creator><creator>Mori, Seiichiro</creator><creator>Kukimoto, Iwao</creator><creator>Muramatsu, Masamichi</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U9</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0001-7767-6795</orcidid></search><sort><creationdate>20150213</creationdate><title>APOBEC3A and 3C decrease human papillomavirus 16 pseudovirion infectivity</title><author>Ahasan, Md Monjurul ; Wakae, Kousho ; Wang, Zhe ; Kitamura, Kouichi ; Liu, Guangyan ; Koura, Miki ; Imayasu, Mieko ; Sakamoto, Naoya ; Hanaoka, Kousei ; Nakamura, Mitsuhiro ; Kyo, Satoru ; Kondo, Satoru ; Fujiwara, Hiroshi ; Yoshizaki, Tomokazu ; Mori, Seiichiro ; Kukimoto, Iwao ; Muramatsu, Masamichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c630t-bc75bc636603380326c06442a5e1bfb5b50b49664532d3233738ac66130b49ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antiviral activity</topic><topic>APOBEC3</topic><topic>Capsid Proteins - physiology</topic><topic>Cytidine Deaminase - genetics</topic><topic>Cytidine Deaminase - physiology</topic><topic>Female</topic><topic>Genome, Viral</topic><topic>HEK293 Cells</topic><topic>Host-Pathogen Interactions</topic><topic>HPV16</topic><topic>Human papillomavirus 16</topic><topic>Human papillomavirus 16 - genetics</topic><topic>Human papillomavirus 16 - pathogenicity</topic><topic>Human papillomavirus 16 - physiology</topic><topic>Humans</topic><topic>Oncogene Proteins, Viral - physiology</topic><topic>Protein Binding</topic><topic>Proteins - genetics</topic><topic>Proteins - physiology</topic><topic>Pseudovirion</topic><topic>Virion - genetics</topic><topic>Virion - pathogenicity</topic><topic>Virion - physiology</topic><topic>Virulence</topic><topic>Virus Assembly</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahasan, Md Monjurul</creatorcontrib><creatorcontrib>Wakae, Kousho</creatorcontrib><creatorcontrib>Wang, Zhe</creatorcontrib><creatorcontrib>Kitamura, Kouichi</creatorcontrib><creatorcontrib>Liu, Guangyan</creatorcontrib><creatorcontrib>Koura, Miki</creatorcontrib><creatorcontrib>Imayasu, Mieko</creatorcontrib><creatorcontrib>Sakamoto, Naoya</creatorcontrib><creatorcontrib>Hanaoka, Kousei</creatorcontrib><creatorcontrib>Nakamura, Mitsuhiro</creatorcontrib><creatorcontrib>Kyo, Satoru</creatorcontrib><creatorcontrib>Kondo, Satoru</creatorcontrib><creatorcontrib>Fujiwara, Hiroshi</creatorcontrib><creatorcontrib>Yoshizaki, Tomokazu</creatorcontrib><creatorcontrib>Mori, Seiichiro</creatorcontrib><creatorcontrib>Kukimoto, Iwao</creatorcontrib><creatorcontrib>Muramatsu, Masamichi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahasan, Md Monjurul</au><au>Wakae, Kousho</au><au>Wang, Zhe</au><au>Kitamura, Kouichi</au><au>Liu, Guangyan</au><au>Koura, Miki</au><au>Imayasu, Mieko</au><au>Sakamoto, Naoya</au><au>Hanaoka, Kousei</au><au>Nakamura, Mitsuhiro</au><au>Kyo, Satoru</au><au>Kondo, Satoru</au><au>Fujiwara, Hiroshi</au><au>Yoshizaki, Tomokazu</au><au>Mori, Seiichiro</au><au>Kukimoto, Iwao</au><au>Muramatsu, Masamichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>APOBEC3A and 3C decrease human papillomavirus 16 pseudovirion infectivity</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2015-02-13</date><risdate>2015</risdate><volume>457</volume><issue>3</issue><spage>295</spage><epage>299</epage><pages>295-299</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) proteins are cellular DNA/RNA-editing enzymes that play pivotal roles in the innate immune response to viral infection. APOBEC3 (A3) proteins were reported to hypermutate the genome of human papillomavirus 16 (HPV16), the causative agent of cervical cancer. However, hypermutation did not affect viral DNA maintenance, leaving the exact role of A3 against HPV infection elusive. Here we examine whether A3 proteins affect the virion assembly using an HPV16 pseudovirion (PsV) production system, in which PsVs are assembled from its capsid proteins L1/L2 encapsidating a reporter plasmid in 293FT cells. We found that co-expression of A3A or A3C in 293FT cells greatly reduced the infectivity of PsV. The reduced infectivity of PsV assembled in the presence of A3A, but not A3C, was attributed to the decreased copy number of the encapsidated reporter plasmid. On the other hand, A3C, but not A3A, efficiently bound to L1 in co-immunoprecipitation assays, which suggests that this physical interaction may lead to reduced infectivity of PsV assembled in the presence of A3C. These results provide mechanistic insights into A3s’ inhibitory effects on the assembly phase of the HPV16 virion. •APOBEC3A, and 3C decrease the infectivity of HPV16 pseudovirion.•APOBEC3A, but not 3C decreases the encapsidated DNA in the pseudovirion.•APOBEC3C, but not 3A binds to HPV16 capsid protein L1 in vitro.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25576866</pmid><doi>10.1016/j.bbrc.2014.12.103</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-7767-6795</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2015-02, Vol.457 (3), p.295-299
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_1676353968
source ScienceDirect Freedom Collection 2022-2024
subjects Antiviral activity
APOBEC3
Capsid Proteins - physiology
Cytidine Deaminase - genetics
Cytidine Deaminase - physiology
Female
Genome, Viral
HEK293 Cells
Host-Pathogen Interactions
HPV16
Human papillomavirus 16
Human papillomavirus 16 - genetics
Human papillomavirus 16 - pathogenicity
Human papillomavirus 16 - physiology
Humans
Oncogene Proteins, Viral - physiology
Protein Binding
Proteins - genetics
Proteins - physiology
Pseudovirion
Virion - genetics
Virion - pathogenicity
Virion - physiology
Virulence
Virus Assembly
title APOBEC3A and 3C decrease human papillomavirus 16 pseudovirion infectivity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A06%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=APOBEC3A%20and%203C%20decrease%20human%20papillomavirus%2016%20pseudovirion%20infectivity&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Ahasan,%20Md%20Monjurul&rft.date=2015-02-13&rft.volume=457&rft.issue=3&rft.spage=295&rft.epage=299&rft.pages=295-299&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2014.12.103&rft_dat=%3Cproquest_cross%3E1655726776%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c630t-bc75bc636603380326c06442a5e1bfb5b50b49664532d3233738ac66130b49ff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1655726776&rft_id=info:pmid/25576866&rfr_iscdi=true